Breast Cancer, Triple Negative Breast Cancer
Conditions
Keywords
triple negative breast cancer, breast cancer
Brief summary
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in Triple Negative Breast Cancer clinical trials, as well as the reasons for withdrawal or discontinuation. The insights gained from this study will ultimately benefit those with Triple Negative Breast Cancer who may be invited to participate in clinical research in the years to come.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥ 18 years * Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study. * Capable of giving signed informed consent, which includes compliance with requirements and restrictions listed in the informed consent form (ICF) and in the protocol
Exclusion criteria
* Pregnant or lactating woman * Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial * Inability to perform regular electronic reporting
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of triple negative breast cancer patients who decide to enroll in a clinical study | 3 months |
| Rate of triple negative breast cancer patients who remain in a clinical study to completion | 12 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed